Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: a long-term mono-center study
Crossref DOI link: https://doi.org/10.1186/s40064-016-1954-6
Published Online: 2016-03-10
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakasu, Yoko
Mitsuya, Koichi
Hayashi, Nakamasa
Okamura, Ikue
Mori, Keita
Enami, Terukazu
Tatara, Raine
Nakasu, Satoshi
Ikeda, Takashi
License valid from 2016-03-10